FOXQ1 and colorectal carcinoma: Collectively, our in vivo experiments unraveled that FOXQ1 knockdown regulated the SIRT1/β-catenin axis and thus reduced the content of CRC-related intestinal pathologic bacteria to repress the xenograft formation of radiation-resistant CRC cells.